celgene corporation news
Your Search Returned 8 tagged news reports
Concert Pharmaceuticals, Celgene to develop deuterium-modified compounds
London :: United Kingdom | 1 month ago
Credibility
Initially, the collaboration will focus on one program, but has the potential to encompass multiple targets. As per the agreement, Concert will receive an upfront payment of more than $300m from Celgene for the development, regulatory and sales
Tags:
The Pros And Cons Of Working At The Best Employer In America
Summit :: NJ :: USA | 4 months ago
Credibility
In the past decade, Celgene Corporation has become a major player in the biopharmaceutical sector. Aside from developing drugs that help people battle cancer and inflammatory disorders, Celgene is also recognized as a great place to work. In fact,
Tags:
2 Biopharmaceutical Stocks with Strong Net Cash
Bothell :: WA :: USA | 7 months ago
Credibility
Jorge is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. All investors know that the greatest risk in biopharmaceutical stocks is the future need of funding of these
Tags:
VentiRx, Celgene to develop cancer drug
London :: United Kingdom | 9 months ago
Credibility
As part of the agreement, Celgene will fund $35m as upfront payment towards research and development of VTX-2337 through pre-defined clinical endpoints. The agreement also provides Celgene with the option to acquire VentiRx whileVentiRx will be
Tags:
Fair Game: Inciting a Revolution: The Investor Spring
Tunis :: Tunisia | 2 years ago
Credibility
Add to Portfolio Mr. O'Donnell, a retired chief executive of the J. Walter Thompson Company, and a man who picks his own stocks , figured that if Twitter, Facebook and other social media could help oppressed citizens in Tunisia and Egypt rally for
Tags:
Array BioPharma receives milestone payment from Celgene
London :: United Kingdom | over 2 years ago
Credibility
If Celgene exercises this option, Celgene would be responsible for additional development and commercialisation of this drug, and Array would be entitled to receive additional milestones, as well as royalties on sales of the drug. As per the terms of
Tags:
Celgene Buying Abraxis For $2.9 Billion
London :: United Kingdom | almost 3 years ago
Credibility
Celgene said it's going to buy Abraxis BioScience for $2.9 billion in cash and stock to boost its presence in cancer drugs. Terms call for Celgene to give each holder of Abraxis $58 a share in cash, 0.2617 Celgene shares as well as one tradeable
Tags:
Celgene to buy Abraxis for $2.9B in biotech deal
New York :: NY :: USA | almost 3 years ago
Credibility
Biotechnology company Celgene says it is expanding its array of cancer treatments by buying Abraxis BioScience for $2.9 billion in cash and stock. The maker of Revlimid and Vidaza says shareholders of Abraxis will receive $58 and
Tags:
